Many individuals in the highest risk category for COVID-19 because of multiple chronic health conditions didn’t think the disease would affect them and reported not changing their behavior at the beginning of Chicago’s outbreak, according to a new study.
Northwestern Medicine has enrolled its first participants in a new international clinical drug trial for COVID-19, testing remdesivir, a novel anti-viral drug developed to treat Ebola, and which has also shown antiviral activity in coronaviruses.
Northwestern University Feinberg School of Medicine students have organized a volunteer effort among medical students and graduate students to help support health care workers, older community members at higher risk for COVID-19 and working parents during the pandemic.
A new potential drug target has been identified in SARS CoV-2 – the virus that causes COVID-19 – by scientists who say multiple drugs will likely be needed to respond to the pandemic.
A potential drug target has been identified in a newly mapped protein of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).
Drinking flavanol-rich cocoa three times a day improved walking distance in individuals with peripheral artery disease, reports a new Northwestern Medicine pilot study published in Circulation Research.
A new study has linked the consumption of red and processed meat with a higher risk of heart disease and death.
Northwestern Medicine scientists were able to significantly reduce brain swelling and damage after a traumatic brain injury by injecting nanoparticles into the bloodstream.
Scientists have discovered a set of neural “conversations” underlying individual neurons’ activity during learned movements, findings with implications for the development of neuroprostheses.
An AI model predicted breast cancer in mammograms more accurately than radiologists, reducing false positives and false negatives, according to a new study.